1. Home
  2. EVOK vs NCPL Comparison

EVOK vs NCPL Comparison

Compare EVOK & NCPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVOK
  • NCPL
  • Stock Information
  • Founded
  • EVOK 2007
  • NCPL 1984
  • Country
  • EVOK United States
  • NCPL United States
  • Employees
  • EVOK N/A
  • NCPL N/A
  • Industry
  • EVOK Biotechnology: Pharmaceutical Preparations
  • NCPL Investment Managers
  • Sector
  • EVOK Health Care
  • NCPL Finance
  • Exchange
  • EVOK Nasdaq
  • NCPL Nasdaq
  • Market Cap
  • EVOK 4.2M
  • NCPL 3.4M
  • IPO Year
  • EVOK 2013
  • NCPL N/A
  • Fundamental
  • Price
  • EVOK $2.45
  • NCPL $1.84
  • Analyst Decision
  • EVOK
  • NCPL
  • Analyst Count
  • EVOK 0
  • NCPL 0
  • Target Price
  • EVOK N/A
  • NCPL N/A
  • AVG Volume (30 Days)
  • EVOK 27.3K
  • NCPL 65.9K
  • Earning Date
  • EVOK 03-13-2025
  • NCPL 03-17-2025
  • Dividend Yield
  • EVOK N/A
  • NCPL N/A
  • EPS Growth
  • EVOK N/A
  • NCPL N/A
  • EPS
  • EVOK N/A
  • NCPL N/A
  • Revenue
  • EVOK $10,249,415.00
  • NCPL $812,612.00
  • Revenue This Year
  • EVOK $99.03
  • NCPL N/A
  • Revenue Next Year
  • EVOK $60.15
  • NCPL $101.16
  • P/E Ratio
  • EVOK N/A
  • NCPL N/A
  • Revenue Growth
  • EVOK 97.84
  • NCPL N/A
  • 52 Week Low
  • EVOK $2.40
  • NCPL $1.41
  • 52 Week High
  • EVOK $12.32
  • NCPL $22.82
  • Technical
  • Relative Strength Index (RSI)
  • EVOK 26.36
  • NCPL 53.60
  • Support Level
  • EVOK $2.51
  • NCPL $1.67
  • Resistance Level
  • EVOK $2.81
  • NCPL $1.84
  • Average True Range (ATR)
  • EVOK 0.29
  • NCPL 0.10
  • MACD
  • EVOK -0.02
  • NCPL 0.02
  • Stochastic Oscillator
  • EVOK 8.12
  • NCPL 92.36

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

About NCPL Netcapital Inc.

Netcapital Inc is a financial technology company. The company facilitates the growth of private companies by providing fundraising services and other consulting services. The company's online private investment platform connects entrepreneurs and investors, enabling companies to raise capital digitally. The Company operates in a single operating segment, which is the provision of fintech services.

Share on Social Networks: